Overview
Rie Ohba practices practicing medicine in Tokyo, Japan.
Her clinical expertise encompasses Myelodysplastic Syndrome (MDS), Multiple Myeloma, and Myelofibrosis.
She is actively involved in clinical research, co-authoring 9 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Rie Ohba
Is Rie Ohba a top-rated expert for Myelodysplastic Syndrome (MDS)?
MediFind is an objective health platform that identifies experts based on real-world data. Rie Ohba is classified as an Experienced expert for Myelodysplastic Syndrome (MDS), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Rie Ohba participate in research or clinical trials?
Yes. Rie Ohba has published 9 articles and abstracts on conditions like Myelodysplastic Syndrome (MDS). You can view a list of Rie Ohba's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Multiple MyelomaMs. Ohba isExperienced. Learn about Multiple Myeloma.
- Myelodysplastic Syndrome (MDS)Ms. Ohba isExperienced. Learn about Myelodysplastic Syndrome (MDS).
- MyelofibrosisMs. Ohba isExperienced. Learn about Myelofibrosis.